Barbara-Jean Bormann-Kennedy

Barbara-Jean Bormann-Kennedy

Director/Board Member presso BIOLINERX LTD.

Patrimonio netto: 127 075 $ in data 31/03/2024

65 anni
Health Technology
Consumer Services
Health Services

Profilo

Barbara-Jean Bormann-Kennedy is currently serving as a Director at Rincon Pharmaceuticals, Inc. and Biotechnology Innovation Organization.
She is also an Independent Director at BioLineRx Ltd., Director at Institute For Pediatric Innovation, Inc., Independent Non-Executive Director at Xeris Biopharma Holdings, Inc., Director at Nanomedical Systems, Inc., and VP-Translational Science & Network Alliances at The Jackson Laboratory.
In her former positions, Dr. Bormann-Kennedy served as President, Chief Executive Officer & Director at BetterLife Pharma, Inc., Chief Executive Officer & Director at Harbour Antibodies BV, Chief Executive Officer & Director at Supportive Therapeutics, and Independent Non-Executive Director at Xeris Pharmaceuticals, Inc. She also held the position of Head-Strategic Alliances at Pfizer Inc. and Senior VP-Business Development & Licensing at Boehringer Ingelheim Pharmaceuticals, Inc. Additionally, she worked as a Consultant at Paperboy Ventures LLC.
Dr. Bormann-Kennedy obtained her undergraduate degree from Fairfield University and her doctorate degree from the University of Connecticut Health Center.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
07/06/2023 57 500 ( 0.04% ) 127 075 $ 31/03/2024
15/03/2024 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Barbara-Jean Bormann-Kennedy

SocietàPosizioneInizio
BIOLINERX LTD. Director/Board Member 19/08/2013
XERIS BIOPHARMA HOLDINGS, INC. Director/Board Member 05/10/2021
Director/Board Member -
Director/Board Member -
Director/Board Member -
Corporate Officer/Principal 01/08/2017
Director/Board Member -
Tutte le posizioni attive di Barbara-Jean Bormann-Kennedy

Precedenti posizioni note di Barbara-Jean Bormann-Kennedy

SocietàPosizioneFine
Director/Board Member 05/10/2021
Supportive Therapeutics Chief Executive Officer 01/07/2017
░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Barbara-Jean Bormann-Kennedy

Formazione di Barbara-Jean Bormann-Kennedy

Fairfield University Undergraduate Degree
University of Connecticut Health Center Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Barbara-Jean Bormann-Kennedy

Relazioni

100 +

Relazioni di 1° grado

16

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
PFIZER, INC.

Health Technology

BETTERLIFE PHARMA INC.

Health Technology

BIOLINERX LTD.

Health Technology

XERIS BIOPHARMA HOLDINGS, INC.

Health Technology

Aziende private10

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Health Services

Health Services

Supportive Therapeutics

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Barbara-Jean Bormann-Kennedy